In the pharmaceutical and veterinary industries, the purity of an active ingredient is not merely a specification; it is a cornerstone of product safety, efficacy, and regulatory compliance. For Flumequine (CAS 42835-25-6), a critical synthetic antibacterial agent used extensively in animal health, maintaining high purity is paramount. As a dedicated manufacturer, our focus is on producing Flumequine that not only meets but exceeds industry expectations for quality and purity.
Flumequine, a member of the quinolone antibiotic class, is indispensable in veterinary medicine for its broad-spectrum activity against a wide range of bacterial pathogens. Its therapeutic effectiveness relies heavily on its precise chemical structure and the absence of significant impurities that could compromise its pharmacological profile or introduce unintended side effects. This is why our manufacturing process is meticulously designed to yield Flumequine with a minimum assay of 99.5%.
The importance of high-purity Flumequine cannot be overstated. In veterinary formulations, even trace amounts of impurities can lead to reduced efficacy, increased resistance development, or adverse reactions in animals. For instance, its application in aquaculture requires a compound that is both potent and safe for aquatic environments. Similarly, when used in livestock and poultry, consistent purity ensures predictable therapeutic outcomes and minimizes the risk of drug residues exceeding permissible limits. This is why we emphasize our adherence to global pharmacopoeial standards like USP, BP, EP, and FCC.
Our manufacturing facility in China is equipped with advanced technology and adheres to strict Good Manufacturing Practices (GMP). This ensures that every batch of Flumequine produced undergoes comprehensive quality control testing. Our commitment to quality is further validated by independent third-party certifications, such as those from SGS. These measures collectively guarantee that the Flumequine we supply is of superior quality and consistently meets the high-purity requirements of our B2B clients worldwide.
For procurement managers and R&D scientists seeking to buy Flumequine, understanding the manufacturer's quality assurance protocols is essential. We provide detailed product specifications and Certificates of Analysis (CoA) for every batch. This transparency allows our clients to confidently integrate our high-purity Flumequine into their product development and manufacturing processes. We are a reliable supplier for CAS 42835-25-6, offering competitive pricing alongside our commitment to quality.
In summary, the emphasis on high purity for Flumequine (CAS 42835-25-6) is driven by the critical need for safety and efficacy in veterinary applications. Our dedication as a manufacturer to achieving and maintaining these stringent purity levels, supported by robust quality systems and certifications, positions us as a premier supplier. We encourage potential clients to inquire about our Flumequine for sale and discover the advantage of partnering with a manufacturer that prioritizes quality above all else.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.